AAAAAA

   
Results: 1-25 |
Results: 25
MASSIVE SPLENOMEGALY IN HAIRY-CELL LEUKEMIA
Authors: TALLMAN MS HAKIMIAN D PETERSON L
Citation: Ms. Tallman et al., MASSIVE SPLENOMEGALY IN HAIRY-CELL LEUKEMIA, Journal of clinical oncology, 16(3), 1998, pp. 1232-1233
LONG-TERM FOLLOW-UP AND LATE COMPLICATIONS OF 2-CHLORODEOXYADENOSINE IN PREVIOUSLY TREATED, ADVANCED, INDOLENT NON-HODGKINS-LYMPHOMA
Authors: KONG LR HUANG CF HAKIMIAN D VARIAKOJIS D KLEIN L KUZEL TM GORDON LI ZANZIG C WOLLINS E TALLMAN MS
Citation: Lr. Kong et al., LONG-TERM FOLLOW-UP AND LATE COMPLICATIONS OF 2-CHLORODEOXYADENOSINE IN PREVIOUSLY TREATED, ADVANCED, INDOLENT NON-HODGKINS-LYMPHOMA, Cancer, 82(5), 1998, pp. 957-964
HYPOCHOLESTEROLEMIA IN HAIRY-CELL LEUKEMIA - A MARKER FOR PROLIFERATIVE ACTIVITY
Authors: PANDOLFINO J HAKIMIAN D RADEMAKER AW TALLMAN MS
Citation: J. Pandolfino et al., HYPOCHOLESTEROLEMIA IN HAIRY-CELL LEUKEMIA - A MARKER FOR PROLIFERATIVE ACTIVITY, American journal of hematology, 55(3), 1997, pp. 129-133
ALL-TRANS-RETINOIC ACID, LOW-DOSE CYTOSINE-ARABINOSIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN ACUTE MYELOGENOUS LEUKEMIA - UPDATE OF AN ILLINOIS CANCER CENTER PHASE-II PILOT-STUDY
Authors: TALLMAN MS MILLER HJ ZANZIG C RADEMAKER A GORDON L HAKIMIAN D VARIAKOJIS D STIFF P FRENCH S BENSON AB
Citation: Ms. Tallman et al., ALL-TRANS-RETINOIC ACID, LOW-DOSE CYTOSINE-ARABINOSIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN ACUTE MYELOGENOUS LEUKEMIA - UPDATE OF AN ILLINOIS CANCER CENTER PHASE-II PILOT-STUDY, Experimental hematology, 24(9), 1996, pp. 549-549
CURRENT RESULTS AND PROSPECTIVE TRIALS OF CLADRIBINE IN CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: TALLMAN MS HAKIMIAN D
Citation: Ms. Tallman et D. Hakimian, CURRENT RESULTS AND PROSPECTIVE TRIALS OF CLADRIBINE IN CHRONIC LYMPHOCYTIC-LEUKEMIA, Seminars in hematology, 33(1), 1996, pp. 23-27
BONE-MARROW BIOPSY FINDINGS AFTER ALL-TRANS-RETINOIC ACID (ATRA) THERAPY IN ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Authors: VARIAKOJIS D TALLMAN MS HAKIMIAN D NAND S MOLNAR Z
Citation: D. Variakojis et al., BONE-MARROW BIOPSY FINDINGS AFTER ALL-TRANS-RETINOIC ACID (ATRA) THERAPY IN ACUTE PROMYELOCYTIC LEUKEMIA (APL), Laboratory investigation, 74(1), 1996, pp. 727-727
RELAPSE OF HAIRY-CELL LEUKEMIA AFTER 2-CHLORODEOXYADENOSINE - LONG-TERM FOLLOW-UP OF THE NORTHWESTERN UNIVERSITY EXPERIENCE
Authors: TALLMAN MS HAKIMIAN D RADEMAKER AW ZANZIG C WOLLINS E ROSE E PETERSON LC
Citation: Ms. Tallman et al., RELAPSE OF HAIRY-CELL LEUKEMIA AFTER 2-CHLORODEOXYADENOSINE - LONG-TERM FOLLOW-UP OF THE NORTHWESTERN UNIVERSITY EXPERIENCE, Blood, 88(6), 1996, pp. 1954-1959
MINIMAL RESIDUAL DISEASE MAY PREDICT BONE-MARROW RELAPSE IN PATIENTS WITH HAIRY-CELL LEUKEMIA TREATED WITH 2-CHLORODEOXYADENOSINE
Authors: WHEATON S TALLMAN MS HAKIMIAN D PETERSON L
Citation: S. Wheaton et al., MINIMAL RESIDUAL DISEASE MAY PREDICT BONE-MARROW RELAPSE IN PATIENTS WITH HAIRY-CELL LEUKEMIA TREATED WITH 2-CHLORODEOXYADENOSINE, Blood, 87(4), 1996, pp. 1556-1560
CLADRIBINE IN THE TREATMENT OF RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: TALLMAN MS HAKIMIAN D ZANZIG C HOGAN DK RADEMAKER A ROSE E VARIAKOJIS D
Citation: Ms. Tallman et al., CLADRIBINE IN THE TREATMENT OF RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of clinical oncology, 13(4), 1995, pp. 983-988
RAPIDLY PROGRESSIVE CUTANEOUS VASCULITIS IN A PATIENT WITH CHRONIC MYELOMONOCYTIC LEUKEMIA
Authors: ROSEN AM HAINES K TALLMAN MS HAKIMIAN D RAMSEYGOLDMAN R
Citation: Am. Rosen et al., RAPIDLY PROGRESSIVE CUTANEOUS VASCULITIS IN A PATIENT WITH CHRONIC MYELOMONOCYTIC LEUKEMIA, American journal of hematology, 50(4), 1995, pp. 310-312
PURINE NUCLEOSIDE ANALOGS - EMERGING ROLES IN INDOLENT LYMPHOPROLIFERATIVE DISORDERS
Authors: TALLMAN MS HAKIMIAN D
Citation: Ms. Tallman et D. Hakimian, PURINE NUCLEOSIDE ANALOGS - EMERGING ROLES IN INDOLENT LYMPHOPROLIFERATIVE DISORDERS, Blood, 86(7), 1995, pp. 2463-2474
MINIMAL RESIDUAL DISEASE IN PATIENTS WITH HAIRY-CELL LEUKEMIA IN COMPLETE REMISSION - COMPARISON OF 2-CHLORODEOXYADENOSINE WITH 2-DEOXYCOFORMYCIN AND PREDICTION OF EARLY RELAPSE
Authors: TALLMAN M HAKIMIAN D WHEATON S KOPECKY K WOLLINS E FOUCAR K CASSILETH P HABERMANN T GREVER M PETERSON LC
Citation: M. Tallman et al., MINIMAL RESIDUAL DISEASE IN PATIENTS WITH HAIRY-CELL LEUKEMIA IN COMPLETE REMISSION - COMPARISON OF 2-CHLORODEOXYADENOSINE WITH 2-DEOXYCOFORMYCIN AND PREDICTION OF EARLY RELAPSE, Blood, 86(10), 1995, pp. 1390-1390
RELAPSE OF HAIRY-CELL LEUKEMIA 2-CHLORODEOXYADENOSINE - LONG-TERM FOLLOW-UP OF THE NORTHWESTERN UNIVERSITY EXPERIENCE
Authors: TALLMAN M HAKIMIAN D ZANZIG C RADEMAKER A WOLLINS E PETERSON L
Citation: M. Tallman et al., RELAPSE OF HAIRY-CELL LEUKEMIA 2-CHLORODEOXYADENOSINE - LONG-TERM FOLLOW-UP OF THE NORTHWESTERN UNIVERSITY EXPERIENCE, Blood, 86(10), 1995, pp. 2419-2419
TC-99M SULFUR COLLOID SCANNING IN PATIENTS WITH HAIRY-CELL LEUKEMIA IN COMPLETE REMISSION (CR) AFTER 2-CHLORODEOXYADENOSINE (2-CDA) WITH HYPOCELLULAR BONE-MARROW BIOPSIES
Authors: SIEGEL R HAKIMIAN D SPIES W WOLLINS E PETERSON L TALLMAN MS
Citation: R. Siegel et al., TC-99M SULFUR COLLOID SCANNING IN PATIENTS WITH HAIRY-CELL LEUKEMIA IN COMPLETE REMISSION (CR) AFTER 2-CHLORODEOXYADENOSINE (2-CDA) WITH HYPOCELLULAR BONE-MARROW BIOPSIES, Blood, 86(10), 1995, pp. 3357-3357
ASSESSMENT OF COMPLETE REMISSION AFTER 2-CHLORODEOXYADENOSINE FOR HAIRY-CELL LEUKEMIA - UTILITY OF MARROW IMMUNOSTAINING AND MEASUREMENT OFSPLENIC INDEX
Authors: TALLMAN MS HAKIMIAN D DYRDA S KILEY C NEMCEK A PETERSON L
Citation: Ms. Tallman et al., ASSESSMENT OF COMPLETE REMISSION AFTER 2-CHLORODEOXYADENOSINE FOR HAIRY-CELL LEUKEMIA - UTILITY OF MARROW IMMUNOSTAINING AND MEASUREMENT OFSPLENIC INDEX, Leukemia & lymphoma, 14, 1994, pp. 133-138
2-CHLORODEOXYADENOSINE IS AN ACTIVE SALVAGE THERAPY IN ADVANCED INDOLENT NON-HODGKINS-LYMPHOMA
Authors: HOFFMAN M TALLMAN MS HAKIMIAN D JANSON D HOGAN D VARIAKOGIS D KUZEL T GORDON LI RAI K
Citation: M. Hoffman et al., 2-CHLORODEOXYADENOSINE IS AN ACTIVE SALVAGE THERAPY IN ADVANCED INDOLENT NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 12(4), 1994, pp. 788-792
PROSPECTIVE EVALUATION OF INTERNAL ADENOPATHY IN A COHORT OF 43 PATIENTS WITH HAIRY-CELL LEUKEMIA
Authors: HAKIMIAN D TALLMAN MS HOGAN DK RADEMAKER AW ROSE E NEMCEK AA
Citation: D. Hakimian et al., PROSPECTIVE EVALUATION OF INTERNAL ADENOPATHY IN A COHORT OF 43 PATIENTS WITH HAIRY-CELL LEUKEMIA, Journal of clinical oncology, 12(2), 1994, pp. 268-272
IMMUNOHISTOCHEMICAL DETECTION OF MINIMAL RESIDUAL DISEASE CORRELATED WITH RELAPSE IN PATIENTS WITH HAIRY-CELL LEUKEMIA TREATED WITH 2-CHLORODEOXYADENOSINE (2-CDA)
Authors: DYRDA S TALLMAN M HAKIMIAN D PETERSON LC
Citation: S. Dyrda et al., IMMUNOHISTOCHEMICAL DETECTION OF MINIMAL RESIDUAL DISEASE CORRELATED WITH RELAPSE IN PATIENTS WITH HAIRY-CELL LEUKEMIA TREATED WITH 2-CHLORODEOXYADENOSINE (2-CDA), Laboratory investigation, 70(1), 1994, pp. 10000107-10000107
ALL-TRANS-RETINOIC ACID (ATRA), LOW-DOSE CYTOSINE-ARABINOSIDE (LDARA-C) AND GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) IN RELAPSED AND REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML) - AN ILLINOIS-CANCER-CENTERPHASE-II PILOT-STUDY
Authors: TALLMAN MS MILLER HJ ZANZIG C RADEMAKER A GORDON L HAKIMIAN D VARIAKOJIS D STIFF P FRENCH S BENSON AB
Citation: Ms. Tallman et al., ALL-TRANS-RETINOIC ACID (ATRA), LOW-DOSE CYTOSINE-ARABINOSIDE (LDARA-C) AND GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) IN RELAPSED AND REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML) - AN ILLINOIS-CANCER-CENTERPHASE-II PILOT-STUDY, Blood, 84(10), 1994, pp. 10000311-10000311
NEW INSIGHTS INTO THE PATHOGENESIS OF COAGULATION DYSFUNCTION IN ACUTE PROMYELOCYTIC LEUKEMIA
Authors: TALLMAN MS HAKIMIAN D KWAAN HC RICKLES FR
Citation: Ms. Tallman et al., NEW INSIGHTS INTO THE PATHOGENESIS OF COAGULATION DYSFUNCTION IN ACUTE PROMYELOCYTIC LEUKEMIA, Leukemia & lymphoma, 11(1-2), 1993, pp. 27-36
ERYTHEMA-NODOSUM ASSOCIATED WITH ALL-TRANS-RETINOIC ACID IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
Authors: HAKIMIAN D TALLMAN MS ZUGERMAN C CARO WA
Citation: D. Hakimian et al., ERYTHEMA-NODOSUM ASSOCIATED WITH ALL-TRANS-RETINOIC ACID IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA, Leukemia, 7(5), 1993, pp. 758-759
BASOPHILIC DIFFERENTIATION IN ACUTE PROMYELOCYTIC LEUKEMIA
Authors: TALLMAN MS HAKIMIAN D SNOWER D RUBIN CM REISEL H VARIAKOJIS D
Citation: Ms. Tallman et al., BASOPHILIC DIFFERENTIATION IN ACUTE PROMYELOCYTIC LEUKEMIA, Leukemia, 7(4), 1993, pp. 521-526
PROTEIN-C, PROTEIN-S, AND ANTITHROMBIN-III LEVELS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA
Authors: TALLMAN MS HAKIMIAN D GREEN D
Citation: Ms. Tallman et al., PROTEIN-C, PROTEIN-S, AND ANTITHROMBIN-III LEVELS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA, Thrombosis and haemostasis, 69(6), 1993, pp. 604-604
DETECTION OF MINIMAL RESIDUAL DISEASE BY IMMUNOSTAINING OF BONE-MARROW BIOPSIES AFTER 2-CHLORODEOXYADENOSINE FOR HAIRY-CELL LEUKEMIA
Authors: HAKIMIAN D TALLMAN MS KILEY C PETERSON L
Citation: D. Hakimian et al., DETECTION OF MINIMAL RESIDUAL DISEASE BY IMMUNOSTAINING OF BONE-MARROW BIOPSIES AFTER 2-CHLORODEOXYADENOSINE FOR HAIRY-CELL LEUKEMIA, Blood, 82(6), 1993, pp. 1798-1802
2-CHLORODEOXYADENOSINE (2-CDA) IS AN ACTIVE SALVAGE THERAPY IN INDOLENT NON-HODGKINS-LYMPHOMA (NHL)
Authors: HOFFMAN M TALLMAN M JANSON D HAKIMIAN D KUZEL T GORDON L RAI KR
Citation: M. Hoffman et al., 2-CHLORODEOXYADENOSINE (2-CDA) IS AN ACTIVE SALVAGE THERAPY IN INDOLENT NON-HODGKINS-LYMPHOMA (NHL), Blood, 82(10), 1993, pp. 10000142-10000142
Risultati: 1-25 |